AGEN (Agenus) Total Enterprise Value
Agenus (AGEN) is accelerating antibody development using AI, although the final validation of drugs remains with physicians. The company relies on a dedicated staff of scientists, retaining key developers through a stock option system. High R&D and patent costs create a significant barrier to entry, which confirms the asset value on the GURU.Markets platform, as reflected in the pakistan chart, which stands at 564.98.
Agenus (AGEN) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Agenus, Inc. (AGEN)
As the owner of a closed patent portfolio in the field of immuno-oncology, Agenus is valued via Enterprise Value, which combines market capitalization with net debt to determine the total cost of acquiring the business. By analyzing the company's aggregate asset valuation, an investor can discern the actual price for buying out all B2B development rights, where growth in this metric signals an inflow of liquidity, while the debt load indicates systemic risks.
Competitor analysis for Agenus
Full Takeover Company Value argenx N.V. ARGX|BNTX (BioNTech Group) - Enterprise Value|ABVX: Total Enterprise Value|Total Company Value ADMA Biologics|PTGX (protagonist-inc.com) - Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|enGene Bio - Enterprise Value|RAPT - Enterprise Value|Enterprise Value JBIO (aerovatetx.com)|aclaristx.com (ACRS) - Full Takeover Company Value|Enterprise Value KYTX (Kyverna Therapeutics, Inc.)|Total Enterprise Value TLSA|Total Company Value Cabaletta Bio, Inc CABA|Business Value Ventyx Biosciences, Inc VTYX|Real Price to Acquire Entire Company THTX (Theratechnologies Inc.)|avalotx.com - Enterprise Value|Total Company Value ELDN (Eledon Pharmaceuticals, Inc.)|CLYM - Company Buyout Price|ZURA: Enterprise Value|aTyr Pharmaceuticals (ATYR) - Enterprise Value|Adagene Inc - Enterprise Value|Full Takeover Company Value Ikena Oncology, Inc.|Shattuck Labs, Inc. - Enterprise Value|Total Enterprise Value EQ (equilliumbio.com)|CNTB - Total Company Value|Immunic Therapeutics - Business Value|Total Company Value Atara Biotherapeutics Inc|IFRX - Full Business Value|Enterprise Value X4 Pharmaceuticals, Inc. XFOR|Adicet Bio, Inc. (ACET) - Value Adjusted for Debt and Cash|CELU (Celularity Inc) - Enterprise Value|Enterprise Value INMB|Barinthus Biotherapeutics (BRNS) - Total Company Value|Value Adjusted for Debt and Cash KZR (kezarlifesciences.com)|SAB Biotherapeutics, Inc. - Total Company Value|Real Price to Acquire Entire Company Akari Therapeutics PLC AKTX|Enlivex Therapeutics, Ltd. - Enterprise Value|Q32 Bio Inc. (QTTB) - Enterprise Value|Real Price to Acquire Entire Company GeoVax Labs, Inc. GOVX|edesabiotech.com (EDSA) - Value Adjusted for Debt and Cash|IBIO: Enterprise Value|Company Buyout Price CARM|Total Company Value XTLB (XTL Biopharmaceuticals, Ltd.)|Real Price to Acquire Entire Company BOLT (boltbio.com)|HCW Biologics - Total Company Value|APVO - Real Price to Acquire Entire Company|AIM ImmunoTech Inc. - Real Price to Acquire Entire Company|ADTX: Enterprise Value|Total Company Value GRI Bio Corp|XORTX Corp (XRTX) - Business Value|Enterprise Value HIND (Vyome Holdings Inc)|Total Enterprise Value revbiosciences.com|Enterprise Value INDP|Enterprise Value Scinai Immunotherapeutics Ltd (SCNI)|CALI (CalciMedica) - Enterprise Value|Full Takeover Company Value Affimed NV AFMD|ALLK (Allakos Therapeutics) - Enterprise Value|HOOK: Total Enterprise Value|Total Company Value igmbio.com|Business Value iTeos Therapeutics Inc|OCEA (Ocean Bio) - Real Price to Acquire Entire Company|Enterprise Value TCBP|THRD (Third Harmonic Bio) - Total Company Value